GENNEX LABORATORIES LTD. Share Price
GENNEX LABORATORIES LTD. Share Price Today
As of 5 Jul 2026, GENNEX LABORATORIES LTD. share price is ₹10.16. The stock opened at ₹10.34, compared to its previous close of ₹10.34. During today's trading session, GENNEX LABORATORIES LTD. share price moved in the range of ₹9.96 to ₹10.61, with an average price of ₹10.29 for the day. Looking at its last 52-week, the stock has touched a low of ₹7.05 and a high of ₹17.25.
GENNEX LABORATORIES LTD. Returns Calculator
GENNEX LABORATORIES LTD. Shareholder Returns
GENNEX LABORATORIES LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
GENNEX LABORATORIES LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹137.90 | ₹86.71 | ₹65.60 | ₹61.21 |
| Other Income | ₹10.43 | ₹4.91 | ₹3.95 | ₹1.38 |
| Total Revenue | ₹148.33 | ₹91.62 | ₹69.56 | ₹62.60 |
| Total Expenses | ₹126.79 | ₹75.13 | ₹63.18 | ₹57.50 |
| Profit Before Tax | ₹21.40 | ₹16.49 | ₹6.37 | ₹5.09 |
| Tax | ₹3.27 | ₹3.32 | ₹1.45 | ₹1.17 |
| Profit After Tax | ₹18.12 | ₹13.18 | ₹4.92 | ₹3.92 |
| EPS - Basic | ₹0.80 | ₹0.67 | ₹0.32 | ₹0.33 |
| EPS - Diluted | ₹0.80 | ₹0.61 | ₹0.32 | ₹0.33 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹21.40 | ₹16.49 | ₹6.37 | ₹5.28 |
| Income before WC changes | ₹17.43 | ₹18.14 | ₹5.98 | ₹7.84 |
| Change in Assets | -₹24.75 | -₹66.88 | ₹5.25 | -₹0.30 |
| Change in Liabilities | -₹0.25 | ₹2.05 | ₹12.45 | ₹5.47 |
| Change in WC | -₹25.00 | -₹64.83 | ₹17.69 | ₹5.18 |
| Cash flow from Operations | -₹10.80 | -₹46.69 | ₹23.68 | ₹11.91 |
| Cash flow from Investing | ₹0.82 | ₹18.91 | -₹38.33 | -₹2.47 |
| Cash flow from Financing | ₹4.57 | ₹73.68 | ₹21.03 | -₹1.83 |
| Total Cash Flow | -₹5.41 | ₹45.91 | ₹6.38 | ₹7.61 |
| Cash (Start of the year) | ₹60.98 | ₹15.06 | ₹8.68 | ₹1.07 |
| Cash (End of the year) | ₹55.57 | ₹60.98 | ₹15.06 | ₹8.68 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹74.91 | ₹68.17 | ₹83.63 | ₹20.84 |
| Current Assets | ₹181.13 | ₹161.81 | ₹48.68 | ₹47.18 |
| Total Assets | ₹256.04 | ₹229.99 | ₹132.32 | ₹68.03 |
| Current Liabilities | ₹44.56 | ₹40.30 | ₹29.51 | ₹24.21 |
| Net Current Asset | ₹136.57 | ₹121.51 | ₹19.17 | ₹22.97 |
| Non-Current Liabilities | ₹16.89 | ₹13.22 | ₹16.29 | ₹0.00 |
| Equity Capital | ₹194.59 | ₹176.46 | ₹86.52 | ₹43.82 |
| Total Equity & Liabilities | ₹256.04 | ₹229.99 | ₹132.32 | ₹68.03 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹94.58 | ₹66.80 | ₹65.10 | ₹61.21 |
| Other Income | ₹9.22 | ₹4.30 | ₹3.40 | ₹1.38 |
| Total Revenue | ₹103.80 | ₹71.10 | ₹68.50 | ₹62.60 |
| Total Expenses | ₹86.59 | ₹56.35 | ₹62.49 | ₹57.50 |
| Profit Before Tax | ₹17.06 | ₹14.75 | ₹6.01 | ₹5.09 |
| Tax | ₹3.02 | ₹2.96 | ₹1.45 | ₹1.17 |
| Profit After Tax | ₹14.04 | ₹11.80 | ₹4.56 | ₹3.92 |
| EPS - Basic | ₹0.62 | ₹0.69 | ₹0.31 | ₹0.31 |
| EPS - Diluted | ₹0.62 | ₹0.69 | ₹0.31 | ₹0.31 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹17.06 | ₹14.87 | ₹6.01 | ₹5.28 |
| Income before WC changes | ₹11.02 | ₹13.06 | ₹5.28 | ₹7.84 |
| Change in Assets | -₹13.43 | -₹60.48 | -₹19.00 | -₹2.31 |
| Change in Liabilities | -₹7.11 | ₹15.08 | -₹0.72 | ₹2.21 |
| Change in WC | -₹20.54 | -₹45.40 | -₹19.73 | -₹0.10 |
| Cash flow from Operations | -₹9.52 | -₹33.43 | -₹14.45 | ₹6.64 |
| Cash flow from Investing | ₹2.63 | ₹0.93 | -₹0.77 | -₹1.26 |
| Cash flow from Financing | ₹1.53 | ₹79.01 | ₹21.35 | ₹1.87 |
| Total Cash Flow | -₹5.36 | ₹46.51 | ₹6.14 | ₹7.24 |
| Cash (Start of the year) | ₹60.96 | ₹14.45 | ₹8.31 | ₹1.07 |
| Cash (End of the year) | ₹55.60 | ₹60.96 | ₹14.45 | ₹8.31 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹31.36 | ₹26.35 | ₹24.06 | ₹21.03 |
| Current Assets | ₹187.02 | ₹178.99 | ₹72.16 | ₹47.18 |
| Total Assets | ₹218.38 | ₹205.34 | ₹96.22 | ₹68.21 |
| Current Liabilities | ₹29.11 | ₹32.82 | ₹15.91 | ₹24.21 |
| Net Current Asset | ₹157.91 | ₹146.17 | ₹56.25 | ₹22.97 |
| Non-Current Liabilities | ₹4.47 | ₹1.76 | ₹1.29 | ₹0.00 |
| Equity Capital | ₹184.80 | ₹170.76 | ₹79.02 | ₹44.00 |
| Total Equity & Liabilities | ₹218.38 | ₹205.34 | ₹96.22 | ₹68.21 |
About GENNEX LABORATORIES LTD.
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The Company has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.
GENNEX LABORATORIES LTD. Financial Highlights
- Revenue: GENNEX LABORATORIES LTD. reported revenue of ₹180.99 crore in FY26 vs ₹158.76 crore in FY25. It showed an increase of 14.00% on a yearly basis.
- Operating Profit: GENNEX LABORATORIES LTD. reported an operating profit of ₹23.24 crore in FY26 vs ₹21.40 crore in FY25. It showed an increase of 8.60% on a year-on-year basis.
- Net Profit: GENNEX LABORATORIES LTD. reported a net profit of ₹20.98 crore in FY26 vs ₹18.12 crore in FY25. It showed an increase of 15.78% on a yearly basis.
GENNEX LABORATORIES LTD. Quarterly Result Highlights
- GENNEX LABORATORIES LTD. reported revenue of ₹62.28 crore in Mar 2026, compared with ₹45.55 crore in Dec 2025, representing an increase of 36.73% on a quarter-on-quarter (QoQ) basis.
- GENNEX LABORATORIES LTD. reported an operating profit of ₹4.67 crore in Mar 2026, compared with ₹6.64 crore in Dec 2025, representing a decrease of 29.67% on a quarter-on-quarter (QoQ) basis.
- GENNEX LABORATORIES LTD. reported a profit of ₹4.46 crore in Mar 2026, compared with ₹5.99 crore in Dec 2025, reflecting a decrease of 25.54% on a QoQ basis.
- The earnings per share (EPS) of GENNEX LABORATORIES LTD. stood at ₹0.80 during Mar 2026.
Similar Stocks
FAQs on GENNEX LABORATORIES LTD. Share Price
What is GENNEX LABORATORIES LTD. share price today?
GENNEX LABORATORIES LTD. share price is ₹10.16 as on 03 Jul, 2026, 15:54 IST.
How has the GENNEX LABORATORIES LTD. share price performed in the past?
In the last 1 year, GENNEX LABORATORIES LTD. delivered a return of -18.78%. The GENNEX LABORATORIES LTD. share price hit a high of ₹17.25 and low of ₹7.05.
How much is the Mutual Fund shareholding in GENNEX LABORATORIES LTD. shares?
The Mutual Fund Shareholding in GENNEX LABORATORIES LTD. was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of GENNEX LABORATORIES LTD. shares ?
The 52-week high and low of GENNEX LABORATORIES LTD. share is ₹17.25 and ₹7.05 as of 03 Jul, 2026.
What is the market cap of GENNEX LABORATORIES LTD.?
The market capitalisation of GENNEX LABORATORIES LTD. is ₹251.21 Crores as on 03 Jul, 2026.
What are the stock symbols of GENNEX LABORATORIES LTD.?
The stock symbol of GENNEX LABORATORIES LTD. is 531739 on the BSE, and the ISIN is INE509C01026.
What was yesterday's closing price for GENNEX LABORATORIES LTD. shares ?
GENNEX LABORATORIES LTD. shares closed yesterday at ₹10.34 on BSE
How to buy GENNEX LABORATORIES LTD. shares?
To buy GENNEX LABORATORIES LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy GENNEX LABORATORIES LTD. shares on Holidays?
No, shares of GENNEX LABORATORIES LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell GENNEX LABORATORIES LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of GENNEX LABORATORIES LTD.?
The PE and PB ratio of GENNEX LABORATORIES LTD. is 12.02 and 1.13 respectively, as on 03 Jul, 2026, 15:54 IST.